Short answer
Incyte (INCY) filed its Q1 2025 10-Q quarterly report on Apr 29, 2025 for the quarter ended Mar 31, 2025. Quarterly revenue was $1.1B (up 19.5% year over year) with net income of $158M.
Q1 2025 key financials · XBRL
- Revenue
- $1.1B
- +19.5% YoY
- Net income
- $158M
- −6.7% YoY
- Operating margin
- 19.5%
- EPS (diluted)
- $0.80
- +6.7% YoY
Source: XBRL data from the Incyte (INCY) Q1 2025 10-Q on SEC EDGAR. USD.
Incyte Q1 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenues $1,052.9M, up 19.5% YoY from $880.9M; JAKAFI $709.4M (+24.1%), OPZELURA $118.7M (+38.6%)
- Net income $158.2M, down 6.6% YoY from $169.5M; basic EPS $0.82 vs $0.76 YoY; operating margin affected by cost increases
- Best segment: JAKAFI revenues $709.4M (+$137.6M), driven by 10% volume growth; worst: ICLUSIG declined slightly to $29.5M from $30.3M
- Operating cash flow $266.1M, up from $218.8M YoY; cash, equivalents, securities $2.4B at quarter-end; minimal investing and stable financing outflows
- Management cautious: ongoing litigation risk for OPZELURA rebates; expects sales allowances to fluctuate, impacts from inflation and government reimbursements
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Incyte quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.